Journal of Nuclear Cardiology

, Volume 1, Issue 3, pp 304–306 | Cite as

Application of nuclear cardiology in the coronary care unit: Achievements and challenges

  • Prediman K. Shah
Challenge Editorials


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bingham S, Berman DS, Shah PK. Nuclear imaging in acute cardiac care. In: Shah PK, ed. Cardiology clinics. Philadelphia: WB Saunders, 1991.Google Scholar
  2. 2.
    Shah PK. Complications of acute myocardial infarction: relative usefulness of non-invasive diagnostic techniques. Cardiovasc Imaging 1990;2:57–67.Google Scholar
  3. 3.
    Bateman TM, Czer LSC, Kass RM, et al. Cardiac causes of shock early after open heart surgery: etiologic classification by radionuclide ventriculography. Circulation 1985;71:1153–61.PubMedGoogle Scholar
  4. 4.
    Botlvinick EH. Hot spot imaging agents for acute myocardial infarction. J Nucl Med 1990;31:143.Google Scholar
  5. 5.
    Johnson LL, Seldin DW. The role of antimyosin antibodies in acute myocardial infarction. Semin Nucl Med 1989;19:238–46.PubMedCrossRefGoogle Scholar
  6. 6.
    Schelbert HR, Henning H, Ashburn WL, et al. Serial measurements of left ventricular ejection fraction by radionuclide angiography early and late after myocardial infarction. Am J Cardiol 1976;38:407–15.PubMedCrossRefGoogle Scholar
  7. 7.
    Shah PK, Pichler M, Berman DS, et al. Left ventricular ejection fraction determined by radionuclide ventriculography in early stages of first transmural myocardial infarction: relation to short term prognosis. Am J Cardiol 1980;45:542–6.PubMedCrossRefGoogle Scholar
  8. 8.
    Meizlish JL, Berger HJ, Plankey M, et al. Functional left ventricular aneurysm formation after acute anterior transmural myocardial infarction: incidence, natural history, and prognostic implications. N Engl J Med 1984;311:1001–6.PubMedGoogle Scholar
  9. 9.
    Shah PK, Maddahi J, Staniloff HM, et al. Variable spectrum and prognostic implications of left and right ventricular ejection fractions in patients with and without clinical heart failure after acute myocardial infarction. Am J Cardiol 1986;58:387–93.PubMedCrossRefGoogle Scholar
  10. 10.
    Silverman KJ, Becker LC, Bulkley BH, et al. Value of early thallium-201 scintigraphy for predicting mortality in patients with acute myocardial infarction. Circulation 1980;61:996–1003.PubMedGoogle Scholar
  11. 11.
    Johnson LL, Seldin DW, Keller AM, et al. Dual-isotope thallium and indium antimyosin SPECT imaging to identify acute infarct patients at further ischemic risk. Circulation 1990;81:37–45.PubMedGoogle Scholar
  12. 12.
    Gibbons RJ. Technetium 99m sestamibi in the assessment of acute myocardial infarction. Semin Nucl Med 1991;21:213–22.PubMedCrossRefGoogle Scholar
  13. 13.
    Liu P. New technetium 99m imaging agents: promising windows for myocardial perfusion and viability. Am J Cardiac Imaging 1992;6:28–41.Google Scholar
  14. 14.
    Gibson RD, Watson DD, Craddock GB, et al. Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography. Circulation 1983;68:321–36.PubMedGoogle Scholar
  15. 15.
    The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983;309:331–9.Google Scholar
  16. 16.
    White HD, Norris RM, Brown MA, et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44–51.PubMedGoogle Scholar
  17. 17.
    Yoshida K, Gould KL. Quantitative relation of myocardial infarct size and myocardial viability by positron emission tomography to left ventricular ejection fraction and 3 year mortality with and without revascularization. J Am Coll Cardiol 1993;22:984–7.PubMedGoogle Scholar
  18. 18.
    Markis JE, Malagold M, Parker JA, et al. Myocardial salvage after intracoronary thrombolysis with streptokinase in acute myocardial infarction: assessment by intracoronary thallium-201. N Engl J Med 1981;305:777–82.PubMedGoogle Scholar
  19. 19.
    Gibbons RJ, Verarri MS, Behrenbeck T, et al. Feasibility of tomographic 99m Tc-hexakis-2 methoxy-2 methylpropyl-isonitrite imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. Circulation 1989;80:1277–86.PubMedGoogle Scholar
  20. 20.
    Gibbons RJ, Verani MS, Behrenbeck T, et al. Feasibility of tomographic Tc-M1B1 imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. Circulation 1989;80:1277.PubMedGoogle Scholar
  21. 21.
    Feiring AJ, Johnson MR, Kioschos JM, et al. The importance of the determination of the myocardial area at risk in the evaluation of the outcome of acute myocardial infarction in patients. Circulation 1987;75:980–7.PubMedGoogle Scholar
  22. 22.
    Santoro GM, Bisi G, Sciagra R, et al. SPECT with Tc-MIBI in acute myocardial infarction before and after thrombolytic treatment: assessment of salvaged myocardium and prediction of late functional recovery. J Am Coll Cardiol 1990;15:301–7.PubMedGoogle Scholar
  23. 23.
    Touchstone DA, Beller GA, Nygaard TW, et al. Effects of successful intravenous reperfusion therapy on regional myocardial function and geometry in humans: a tomographic assessment using two-dimensional echocardiography. J Am Coll Cardiol 1989;13:1506–13.PubMedGoogle Scholar
  24. 24.
    Braunwald E, Kloner R. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982;66:1146–9.PubMedGoogle Scholar
  25. 25.
    Okada RD, Boucher CA. Differentiation of viable and nonviable myocardium after acute reperfusion using serial thallium-201 imaging. Am Heart J 1987;113:241–50.PubMedCrossRefGoogle Scholar
  26. 26.
    Bonow R, Dilsizian V, Cuocolo A, et al. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction: comparison of thallium scintigraphy with reinjection and PET imaging with F-18 fluorodeoxyglucose. Circulation 1991;83:26.PubMedGoogle Scholar
  27. 27.
    Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884–8.PubMedGoogle Scholar
  28. 28.
    Brunken RC, Kottous S, Nienaber CA, et al. PET detection of viable tissue in myocardial segments with persistent defects in T1-201 SPECT. Radiology 1989;172:65–73.PubMedGoogle Scholar
  29. 29.
    Eitzman D, Al-Auar Z, Kanter HL, et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992;20:559–65.PubMedGoogle Scholar
  30. 30.
    Dilsizian V, Filardi-Perrone P, Arrighi JA, et al. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution: thallium imaging for assessing viable myocardium: comparison with metabolic activity by positron emission tomography. Circulation 1993;88:941–52.PubMedGoogle Scholar
  31. 31.
    Kaul S. Doppler echocardiography in critically ill cardiac patients. In: Shah PK, ed. Cardiology clinics. Philadelphia: WB Saunders, 1991.Google Scholar
  32. 32.
    Cigarroa CG, deFilippi CR, Brickner EM, et al. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 1993;88:430–7.PubMedGoogle Scholar
  33. 33.
    Smart SC, Sawada S, Ryan T, et al. Low dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993;88:405–16.PubMedGoogle Scholar
  34. 34.
    Quinones MA, Cheirif J. New perspectives for perfusion imaging in echocardiography. Circulation 1991;83(suppl):104–10.Google Scholar
  35. 35.
    Kaul S, Pandian NG, Gillam LD, et al. Contrast echocardiography in acute myocardial ischemia, III: an in vivo comparison of the extent of abnormal wall motion with the area at risk for necrosis. J Am Coll Cardiol 1986;7:383–92.PubMedGoogle Scholar
  36. 36.
    Geny B, Mettauer B, Muan B, et al. Safety and efficacy of a new transpulmonary echo contrast agent in echocardiographic studies in patients. J Am Coll Cardiol 1993;22:1193–8.PubMedCrossRefGoogle Scholar
  37. 37.
    Badimon JJ, Perlman J. Atherosclerotic plaque detection by nuclear magnetic resonance and radiolabeled autologous low-density lipoprotein. Am J Cardiac Imaging 1992;6:325–32.Google Scholar
  38. 38.
    Stratton JR. Thrombosis imaging with indium-111-labeled platelets. In: Marcus ML, Schelbert HR, Skorton DJ, Wolf GL, Braunwald E, eds. Cardiac imaging. Philadelphia: WB Saunders, 1991.Google Scholar

Copyright information

© American Society of Nuclear Cardiology 1994

Authors and Affiliations

  • Prediman K. Shah
    • 1
  1. 1.Los Angeles School of MedicineUniversity of CaliforniaLos Angeles

Personalised recommendations